Inovio Pharmaceuticals, Inc. , a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases.
Inovio Pharmaceuticals stock last closed at $1.22, up 0% from the previous day, and has decreased 41.06% in one year. It has overperformed other stocks in the Biotechnology industry by 0.36 percentage points. Inovio Pharmaceuticals stock is currently +18.45% from its 52-week low of $1.03, and -59.05% from its 52-week high of $2.98.
As of May 19, 2026, there are 82.27M shares of INO outstanding. The market capitalization of INO is $100.37M. In the last 24 hours, 4.84M INO shares were traded.
You will need an online brokerage account in order to access the NASDAQ market and buy INO stock.
Based on our experience, eToro is the best online stock brokerage. eToro gives you:
Get $10 towards your stock purchase by creating an account with eToro today. This offer is only for US users.
Open eToro AccountNow that you've chosen the right brokerage, it's time to fill out some personal information so you can buy INO today.
Now that you've filled out your info on the stock trading app, you need to deposit funds:
Watch the video below to see the process of depositing funds into your investment account.
Once you have selected the best place to buy Inovio Pharmaceuticals stock, it's important to evaluate their stock prior to buying, so you actually wrap your head around the risk as well as the opportunity.
WallStreetZen was built to help average investors do more in-depth fundamental analysis in less time.
You can view all of the due diligence checks on INO's stock page.
Analysts use many financial metrics, analyses, models, and charts to gauge INO's fair value.
Using relative valuations metrics:
You can do more valuation analysis on INO's stock here.
You can dive deeper into what analysts are projecting on the Inovio Pharmaceuticals stock forecast page.
Last year, INO revenue was $0.00. During the past 5 year, INO's revenue has increased by -100% per year. This was slower than the Biotechnology industry average of 29.7%.
Dig into INO's earnings and revenue performance here.
In the past 12 months, insiders at INO have sold more shares than they have bought.
Laurent Humeau, Chief Scientific Officer of INO, was the latest INO insider to sell. They sold $2,225.60 worth of INO shares on May 15, 2026.
Dig into more about who owns INO shares here.
No, Inovio Pharmaceuticals doesn't provide an income stream by paying out dividends.
One of the reasons eToro is our favorite brokerage is because of its social trading community.
Click below to learn what other community members have to say.
You have two primary types of orders:
Click the Open button and your broker will place your order.
If you want more help buying stocks on eToro, watch the helpful video below:
Now that you own some INO stock, you'll want to keep up with your stock purchase.
Add INO to a watchlist to see the latest developments about your INO stock.
To reiterate, here are the 6 steps for buying Inovio Pharmaceuticals stock:
If you are looking for a brokerage, eToro is our favorite option.
Get Started with eToro TodayIf you want to get updates on your new investment in Inovio Pharmaceuticals, create a watchlist today.